Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 201–300 of 902
Growth Factors For Wound Healing
ten Dijke, P., & Iwata, K. K. (1989) · Nature Biotechnology · doi:10.1038/nbt0889-793 · Cited by 115
Bogdan, N., Rodríguez, E., Sanz-Rodríguez, F., de la Cruz, M. D. C. I., Juarranz, Á., Jaque, D., Solé, J., & Capobianco, J. (2012) · Nanoscale · doi:10.1039/c2nr30982c · Cited by 107
Transforming growth factor‐βs inhibit mitogen‐stimulated proliferation of astrocytes
Hunter, K. E., Sporn, M. B., & Davies, A. M. (1993) · Glia · doi:10.1002/glia.440070303 · Cited by 106
Tyrrell, D. J., Ishihara, M., Rao, N., Horne, A., Kiefer, M. C., Stauber, G. B., Lam, L. H., & Stack, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53450-5 · Cited by 107
On Scleroderma: Mast Cells, Endothelial Cells, and Fibroblasts
Claman, H. N. (1989) · JAMA · doi:10.1001/jama.1989.03430090068035 · Cited by 112
Moy, F. J., Safran, M., Seddon, A. P., Kitchen, D. B., Böhlen, P., Aviezer, D., Yayon, A., & Powers, R. (1997) · Biochemistry · doi:10.1021/bi9625455 · Cited by 112
Sternfeld, M. D., Robertson, J. E., Shipley, G. D., Tsai, J., & Rosenbaum, J. T. (1989) · Current Eye Research · doi:10.3109/02713688908997395 · Cited by 112
Vernon, R. K., & SPICER, L. J. (1994) · Journal of Animal Science · doi:10.2527/1994.72102696x · Cited by 111
Claude, P., Parada, I., Gordon, K. A., D'Amore, P. A., & Wagner, J. A. (1988) · Neuron · doi:10.1016/0896-6273(88)90126-2 · Cited by 110
The role of perlecan in arterial injury and angiogenesis
SEGEV, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.028 · Cited by 97
“When complexed with heparan sulfate chains, FGF-2 is protected from proteolytic degradation [63,64] and maintains a capacity for long-term stimulation of EC inducing proliferation, migration [65] and increased plasminogen activator activity [62,65].”
Cronauer, M. V., Hittmair, A., Eder, I. E., Hobisch, A., Čulig, Z., Ramoner, R. E., Zhang, J., Bartsch, G. H., Reissigl, A. E., Radmayr, C., et al. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970601)31:4<223::aid-pros3>3.0.co;2-l · Cited by 109
Ortega, S., Schaeffer, M., Soderman, D. D., DiSalvo, J., Linemeyer, D. L., Giménez‐Gallego, G., & Thomas, K. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67674-x · Cited by 109
A functional extracellular matrix biomaterial derived from ovine forestomach
Lun, S., Irvine, S. M., Johnson, K. D., Fisher, N. J., Floden, E. W., Negron, L., Dempsey, S. G., McLaughlin, R. J., Vasudevamurthy, M. K., Ward, B. R., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.025 · Cited by 109
“HS also binds free FGF2, stabilizing the growth factor and prolonging its circulating half-life [41].”
Moses, M. A., & Langer, R. (1991) · Nature Biotechnology · doi:10.1038/nbt0791-630 · Cited by 108
Adenovirally expressed basic fibroblast growth factor rescues photoreceptor cells in RCS rats.
Akimoto, M., Miyatake, S.-I., Kogishi, J.-I., Hangai, M., Okazaki, K., TAKAHASHI, J. C., Saiki, M., Iwaki, M., & Honda, Y. (1999) · PubMed · Cited by 108
The Fibroblast Growth Factors: An Emerging Family of Neural Growth Factors
Wagner, J. A. (1991) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75747-1_6 · Cited by 108
Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases
Madzharova, E., Kastl, P., Sabino, F., & Keller, U. A. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123077 · Cited by 108
“FGF2 binding to heparin, an extremely sulfated HS variant expressed by connective-tissue type macrophages, stabilizes FGF2 and protects it from degradation by proteolysis [109,110].”
BackgroundHydrogels for therapeutic cardiovascular angiogenesis
Rufaihah, A. J., & Seliktar, D. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.003 · Cited by 107
Gene therapy and tissue engineering for sports medicine
Huard, J., Li, Y., Peng, H., & Fu, F. H. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.344 · Cited by 93
“Various strategies, including the use of polymers, pumps, and heparin, have been investigated as possible methods by which to achieve constant levels of growth factors at a given injured site [7,8].”
BackgroundLin, Y., & Grinnell, F. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.3.663 · Cited by 106
Park, J., Lee, S. J., Lee, H., Park, S. A., & Lee, J. Y. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.05.048 · Cited by 106
Wu, J., Zhu, J., Wu, Q., An, Y., Wang, K., Xuan, T., Zhang, J., Song, W., He, H., Song, L., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c18388 · Cited by 105
Fibroblast growth factor-2 (FGF-2) in the nucleus: Translocation process and targets
Amalric, F., Bouche, G., Bonnet, H., Brethenou, P., Roman, A. M., Truchet, I., & Quarto, N. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90443-x · Cited by 105
Transforming growth factor‐β1 binds to immobilized fibronectin
Mooradian, D. L., Lucas, R., Weatherbee, J. A., & Furcht, L. T. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240410404 · Cited by 103
Díaz, A., Reginato, A. M., & Jiménez, S. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50092-8 · Cited by 103
Mascarelli, F., Raulais, D., Counis, M. F., & Courtois, Y. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90554-7 · Cited by 102
Öztürk, E., Arlov, Ø., Aksel, S., Li, L., Ornitz, D. M., Skjåk‐Bræk, G., & Zenobi‐Wong, M. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201600092 · Cited by 101
Wissink, M., Beernink, R. H. J., Scharenborg, N. M., Poot, A. A., Engbers, G. H. M., Beugeling, T., van Aken, W. G., & Feijén, J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00202-9 · Cited by 101
Caldwell, M. A., & Svendsen, C. N. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6815 · Cited by 101
Nugent, M. A., Karnovsky, M. J., & Edelman, E. R. (1993) · Circulation Research · doi:10.1161/01.res.73.6.1051 · Cited by 102
On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans
Sasisekharan, R., Ernst, S., & Venkataraman, G. (1997) · Angiogenesis · doi:10.1023/a:1018318914258 · Cited by 99
Rusnati, M., Urbinati, C., & Presta, M. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041540119 · Cited by 99
Sakaguchi, K., Yanagishita, M., Takeuchi, Y., & Aurbach, G. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89640-9 · Cited by 86
Loh, X. J., Nguyen, V., Kuo, N., & Li, J. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm03051a · Cited by 97
D’Angelo, G., Martini, J., Iiri, T., Fantl, W. J., MARTIAL, J. A., & Weiner, R. I. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.5.0280 · Cited by 97
Raub, T. J., & Newton, C. R. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490118 · Cited by 89
Heart Regeneration with Engineered Myocardial Tissue
Coulombe, K. L. K., Bajpai, V. K., Andreadis, S. T., & Murry, C. E. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152344 · Cited by 95
“Heparin binding also prevents inactivation (174) and proteolytic degradation (175) of growth factors, thereby enhancing growth factor half-life.”
BackgroundFibroblast growth factors as angiogenesis factors: New insights into their mechanism of action
Klein, S. S., Roghani, M., & Rifkin, D. B. (1997) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9006-9_7 · Cited by 96
Lovicu, F. J., & McAvoy, J. W. (1993) · PubMed · Cited by 95
Souza, P. R., de Oliveira, A. C., Vilsinski, B. H., Kipper, M. J., & Martins, A. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050621 · Cited by 93
Yoon, J. J., Chung, H. J., & Park, T. G. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31271 · Cited by 93
“Heparin in the ECM acts as an anchoring molecule for bFGF, enabling it to diffuse out in a sustained manner while stabilizing its structure and bioactivity.(18,19) For this reason, many growth factor delivery systems based on polymeric materials were conjugated or blended with heparin moieties in the structure to mimi…”
BackgroundResultDistribution of insulin-like growth factor peptides in the developing chick embryo
Ralphs, J. R., Wylie, L., & Hill, D. J. (1990) · Development · doi:10.1242/dev.109.1.51 · Cited by 93
Ristow, H., & Messmer, T. O. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041370210 · Cited by 92
Potentiation of Endothelial Cell Proliferation by Fibrin(ogen)-bound Fibroblast Growth Factor-2
Sahni, A., Sporn, L. A., & Francis, C. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.14936 · Cited by 92
Reynolds, A. R., & Kyprianou, N. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706635 · Cited by 91
“One of the more unique characteristics of FGFs is their high affinity for heparin sulphate proteoglycans, and heparin analogues, in the ECM (see Gospodarowicz & Cheng, 1986; Ornitz & Itoh, 2001).”
BackgroundKaji, T., Yamada, A., Miyajima, S., Yamamoto, C., Fujiwara, Y., Wight, T. N., & Kinsella, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1463 · Cited by 91
Modulation of human endothelial cell proliferation and migration by fucoidan and heparin
Giraux, J.-L., Matou, S., Bros, A., Tapon‐Bretaudière, J., Letourneur, D., & Fischer, A. (1998) · European Journal of Cell Biology · doi:10.1016/s0171-9335(98)80094-0 · Cited by 92
Isolation of a Receptor for Acidic and Basic Fibroblast Growth Factor from Embryonic Chick
Burrus, L. W., & Olwin, B. B. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51516-7 · Cited by 85
Perineuronal nets of extracellular matrix around parvalbumin‐containing neurons of the hippocampus
Celio, M. R. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030709 · Cited by 89
Elia, R., Fuegy, P. W., VanDelden, A., Firpo, M. A., Prestwich, G. D., & Peattie, R. A. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.043 · Cited by 89
Rodier, J. M. P., Vallés, A. M., Denoyelle, M., Thiery, J. P., & Boyer, B. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.3.761 · Cited by 88
“Heparin (Choay laboratories, Paris, France) was added to stabilize its biological activity (19).”
BackgroundCoordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis
Jackson, R. A., Nurcombe, V., & Cool, S. M. (2006) · Gene · doi:10.1016/j.gene.2006.04.028 · Cited by 90
Seno, M., Sasada, R., Kurokawa, T., & Igarashi, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15395.x · Cited by 88
Current Understanding of the Applications of Photocrosslinked Hydrogels in Biomedical Engineering
Liu, J., Su, C., Chen, Y., Tian, S., Lu, C., Huang, W. P., & Lv, Q. (2022) · Gels · doi:10.3390/gels8040216 · Cited by 88
“Heparin specifically binds to growth factors, so it has important value in growth-factor-delivery systems [55,56].”
BackgroundSperinde, G. V., & Nugent, M. A. (1998) · Biochemistry · doi:10.1021/bi980600z · Cited by 89
Fibroblast Growth Factor and Epidermal Growth Factor in Hair Development.
du Cros, D. L. (1993) · Journal of Investigative Dermatology · doi:10.1016/0022-202x(93)90509-g · Cited by 30
Barr, P. J., Cousens, L. S., Lee-Ng, C. T., Medina-Selby, A., Masiarz, F. R., Hallewell, R. A., Chamberlain, S. H., Bradley, J. D., Lee, D., & Steimer, K. S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37616-6 · Cited by 85
Sudhalter, J., Folkman, J., Svahn, C. M., Bergendal, K., & D'Amore, P. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83515-3 · Cited by 85
FGF-1: From Biology Through Engineering to Potential Medical Applications
Zakrzewska, M., Marcinkowska, E., & Więdłocha, A. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713120 · Cited by 85
Heparin stabilizes FGF-2 and modulates striatal precursor cell behavior in response to EGF
Caldwell, M. A., Garcion, E., terBorg, M. G., He, X., & Svendsen, C. N. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.007 · Cited by 88
Turnover of Heparan Sulfate Depends on 2-O-Sulfation of Uronic Acids
Bai, X., Bame, K. J., Habuchi, H., Kimata, K., & Esko, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23172 · Cited by 84
Mueller, S. N., Thomas, K. A., Salvo, J. D., & Levine, E. M. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400306 · Cited by 84
Pepper, M. S., Vassalli, J. D., Orci, L., Montesano, R., Wilks, J. W., & Schweigerer, L. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550403 · Cited by 84
Han, R. N. N., Liu, J., Tanswell, A. K., & Post, M. (1992) · Pediatric Research · doi:10.1203/00006450-199205000-00004 · Cited by 83
Huang, Y., & Yang, Y. (2013) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1752 · Cited by 82
“Previous studies have indicated that heparin protects heparin-binding proteins, e.g. aFGF and bFGF, from inactivation by heat or proteolysis (Gospodarowicz and Cheng, 1986).”
Backgroundde Iongh, R. U., & McAvoy, J. W. (1992) · Growth Factors · doi:10.3109/08977199209011018 · Cited by 82
Clinical applications of heparin‐binding growth factors
Lobb, R. R. (1988) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1988.tb01020.x · Cited by 82
Blaber, S. I., Culajay, J. F., Khurana, A., & Blaber, M. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)76904-3 · Cited by 81
“Early characterization of FGF-1 indicated that binding of heparin could protect the protein from denaturation by acid, proteolysis, and mild oxidation ( Gospodarowicz and Cheng, 1986; Rosengart et al., 1988; Linemeyer et al., 1990).”
BackgroundCulajay, J. F., Blaber, S. I., Khurana, A., & Blaber, M. (2000) · Biochemistry · doi:10.1021/bi9927742 · Cited by 81
Vicatos, S., Roca, M., & Warshel, A. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22481 · Cited by 80
The FGF21 Receptor Signaling Complex
Kilkenny, D. M., & Rocheleau, J. V. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.02.008 · Cited by 80
“Critically, this membrane signaling complex has been modeled as a 2:2:2 ratio of HSC: FGF:FGFR (Schlessinger et al., 2000).”
BackgroundThrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor
Lobb, R. R. (1988) · Biochemistry · doi:10.1021/bi00407a045 · Cited by 80
Lee, H., Struman, I., Clapp, C., MARTIAL, J. A., & Weiner, R. I. (1998) · Endocrinology · doi:10.1210/endo.139.9.6194 · Cited by 79
“BBEC were isolated as previously described (25).”
Sulfated glycosaminoglycans modify growth factor‐induced neurite outgrowth in PC12 cells
Damon, D. H., D'Amore, P. A., & Wagner, J. A. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041350217 · Cited by 79
The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation
Masuoka, K., Ishihara, M., Asazuma, T., Hattori, H., Matsui, T., Takase, B., Kanatani, Y., Fujita, M., Saito, Y., Yura, H., et al. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.061 · Cited by 78
Zetter, B. R. (1988) · CHEST Journal · doi:10.1378/chest.93.3_supplement.159s · Cited by 78
Weich, H. A., Iberg, N., Klagsbrun, M., & Folkman, J. (1990) · Growth Factors · doi:10.3109/08977199009167026 · Cited by 78
Levinson, C., Lee, M., Applegate, L. A., & Zenobi‐Wong, M. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.017 · Cited by 78
Aggregation Pathway of Recombinant Human Keratinocyte Growth Factor and Its Stabilization
Chen, B., Arakawa, T., Morris, C. F., Kenney, W. C., Wells, C. M., & Pitt, C. G. (1994) · Pharmaceutical Research · doi:10.1023/a:1018905720139 · Cited by 77
Measurement of Cytokines in Clinical Samples Using Immunoassays: Problems and Pitfalls
Banks, R. E. (2000) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360091174187 · Cited by 77
Properties of fucoidan from Cladosiphon okamuranus tokida in gastric mucosal protection
Shibata, H., Kimura‐Takagi, I., Nagaoka, M., Hashimoto, S., Aiyama, R., Iha, M., Ueyama, S., & Yokokura, T. (2000) · BioFactors · doi:10.1002/biof.5520110402 · Cited by 67
“This instability is prevented by binding to heparin [15], a low-affinity receptor for bFGF [19].”
BackgroundBasic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells
Bruno, E., Cooper, R. J., Wilson, E. L., Jl, G., & Hoffman, R. (1993) · Blood · doi:10.1182/blood.v82.2.430.430 · Cited by 77
Targeted Drug Delivery via the Use of ECM-Mimetic Materials
Hwang, J., Sullivan, M. O., & Kiick, K. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00069 · Cited by 76
“…interaction is highly specific, involving electrostatic forces between the negatively charged heparin and positively charged amino acid residues (e.g., lysine and arginine), and both protects the stability of proteins and increases their affinity for cell receptors (Gospodarowicz and Cheng, 1986).”
BackgroundJasuja, R., Allen, B. L., Pappano, W. N., Rapraeger, A. C., & Greenspan, D. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408129200 · Cited by 78
Logeart-Avramoglou, D., & Jozefonvicz, J. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(1999)48:4<578::aid-jbm26>3.0.co;2-8 · Cited by 72
Tan, E. M. L., Rouda, S., Greenbaum, S. S., Moore, J. H., Fox, J. W., & Sollberg, S. (1993) · PubMed Central · Cited by 76
Modrowski, D., Baslé, M. F., Lomri, A., & Marie, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9178 · Cited by 76
Phase separation on cell surface facilitates bFGF signal transduction with heparan sulphate
Xue, S., Zhou, F., Zhao, T., Zhao, H., Wang, X., Chen, L., Li, J., Tan, T., & Luo, S. (2022) · Nature Communications · doi:10.1038/s41467-022-28765-z · Cited by 75
Controlled release of FGF‐2 using fragmin/protamine microparticles and effect on neovascularization
Nakamura, S., Kanatani, Y., Kishimoto, S., Nakamura, S., Ohno, C., Horio, T., Fujita, M., Hattori, H., Tanaka, Y., Kiyosawa, T., et al. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32265 · Cited by 75
Raub, T. J., & Audus, K. L. (1990) · Journal of Cell Science · doi:10.1242/jcs.97.1.127 · Cited by 74
Powell, P. P., Wang, C.-C., Horinouchi, H., Shepherd, K., Jacobson, M., Lipson, M., & Jones, R. C. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.4.2994 · Cited by 75
“Acting as stabilizing factors, heparin or heparan sulfate glycoprotein protects FGF2 (and FGF1) from inactivation and from degradation (37, 38).”
BackgroundBasic fibroblast growth factor promotes in vivo cerebral angiogenesis in chronic forebrain ischemia
Lyons, M., Anderson, R. E., & Meyer, F. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90784-s · Cited by 75
Beierle, J. M., Yoshimatsu, K., Chou, B., Mathews, M. A. A., Lesel, B. K., & Shea, K. J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404881 · Cited by 74
A Synthetic Peptide Fragment of Human MEPE Stimulates New Bone Formation In Vitro and In Vivo
Hayashibara, T., Hiraga, T., Yi, B., Nomizu, M., Kumagai, Y., Nishimura, R., & Yoneda, T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301263 · Cited by 74
“GAGs, heparin, and heparan sulfate are shown to protect heparin-binding growth factors such as FGFs and granulocyte-macrophage colony-stimulating factor (GM-CSF) from degradation and inactivation.((28,29)) Heparan sulfate is found to be essential for FGF signaling through direct association with FGFs and FGF receptors.”
BackgroundIn vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2
Ribatti, D., Leali, D., Vacca, A., Giuliani, R., Gualandris, A., Roncali, L., Nolli, M. L., & Presta, M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.23.4213 · Cited by 74
Identification of the fibroblast growth factor receptor in human vascular endothelial cells
Neufeld, G., & Gospodarowicz, D. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041360321 · Cited by 74
Self-citationAdvances in adhesive hydrogels for tissue engineering
Yang, J. Z., Yu, H., Wang, L., Liu, J., Liu, X., Hong, Y., Huang, Y., & Ren, S. (2022) · European Polymer Journal · doi:10.1016/j.eurpolymj.2022.111241 · Cited by 73
Wang, H., Feng, Y., Fang, Z., Xiao, R., Yuan, W., & Khan, M. (2013) · Macromolecular Research · doi:10.1007/s13233-013-1105-7 · Cited by 73
Nur‐E‐Kamal, A., Ahmed, I., Kamal, J., Babu, A. N., Schindler, M., & Meiners, S. A. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9654-8 · Cited by 73
“Whether this enhanced stability of covalently bound FGF-2 is a result of molecular changes that are similar to those induced by heparin and previously shown to protect it from heat and acid inactivation [26] and from proteolytic digestion [27–29] remains to be determined.”
BackgroundYing, P., Shakibaei, M., Patankar, M. S., Clavijo, P., Beavis, R. C., Clark, G. F., & Frevert, U. (1997) · Experimental Parasitology · doi:10.1006/expr.1996.4134 · Cited by 75
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.